Fig. 3From: α-linolenic acid and docosahexaenoic acid, alone and combined with trastuzumab, reduce HER2-overexpressing breast cancer cell growth but differentially regulate HER2 signaling pathwaysEffect of DHA and TRAS, alone and in combination, on the growth of BT-474 cells. n = 3Back to article page